Hofseth BioCare ASA (HOFBF)

0.2200 0.0000 (0.00%) At close: 04:20PM EDT

Hofseth BioCare ASA

Keiser Wilhelms gate 24
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 69

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jon Olav Odegard	Chief Executive Officer	154.81k	N/A	N/A
Dr. Bomi Framroze	Chief Scientific Officer	1.98M	N/A	1961
Mr. James Berger	Chief Commercial Officer	710.87k	N/A	N/A
Ms. Angelika Florvaag	Chief Quality Officer	74.81k	N/A	N/A
Ms. Christel Elise Kanli	CFO & COO	N/A	N/A	N/A
Dr. Crawford Currie	Head of Medical R&D and Director	N/A	N/A	N/A
Dr. Tanja Schaffer	EVP of Global Ingredients Division & CEO of HBC Switzerland GmbH	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.

Corporate governance

Hofseth BioCare ASA’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 10; Board: 4; Shareholder rights: 1; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.